Sharps Technology, Inc. (NASDAQ:STSS) Sees Large Decrease in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 110,000 shares, a drop of 19.8% from the December 15th total of 137,200 shares. Currently, 6.4% of the company’s stock are short sold. Based on an average daily volume of 178,600 shares, the days-to-cover ratio is presently 0.6 days.

Sharps Technology Price Performance

Shares of NASDAQ STSS traded up $0.01 during mid-day trading on Friday, reaching $1.89. The company had a trading volume of 2,296 shares, compared to its average volume of 35,641. The stock has a 50 day simple moving average of $2.43. Sharps Technology has a twelve month low of $1.70 and a twelve month high of $18.15. The firm has a market capitalization of $3.86 million, a PE ratio of -0.23 and a beta of 1.56.

Hedge Funds Weigh In On Sharps Technology

A hedge fund recently bought a new stake in Sharps Technology stock. Garden State Investment Advisory Services LLC bought a new stake in Sharps Technology, Inc. (NASDAQ:STSS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 8.45% of Sharps Technology as of its most recent SEC filing. Hedge funds and other institutional investors own 17.17% of the company’s stock.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.